NeuroCytotron in the Treatment of Autism Spectrum Disorder

Clinical trial NCT06477263 · RECRUITING

Trial details

NCT number: NCT06477263
Sponsor: Neurocytonix, Inc.
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Autism Spectrum Disorder

Start date: 2024-07-15
Primary completion: 2025-03-06
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.